Spectrum Brands reaffirms distribution-only agreement with King of Shaves
MADISON, Wis. — Responding to weekend press reports, consumer products company Spectrum Brands issued a statement indicating that it has not offered to acquire King of Shaves, a U.K.-based company with whom Spectrum has a multiyear distribution agreement through its Remington North America division.
Spectrum Brands signed in November 2010 a multiyear agreement with the King of Shaves, under which Spectrum’s Remington division, a provider of Remington-branded electric shavers, grooming and styling products, distributes King of Shaves products in the United States, Canada and Mexico.
In reaffirming its distribution-only agreement with King of Shaves, Spectrum stated that it looks forward to entering the U.S. market for men’s wet shaving with a full line of products.
Spectrum Brands’ Remington division this fall is launching its Remington King of Shaves Azor 5 line of five-blade razors, disposable cartridges and shaving gels in the United States. Remington also will distribute the King of Shaves branded men’s grooming products.
The U.S. men’s wet shave market, including handles, cartridges and disposable razors, is estimated at nearly $2 billion in annual retail sales, and growing at a compound annual rate of approximately 4%, the company stated.
FDA approves Perrigo, Cobrek dermatitis drug
ALLEGAN, Mich. — The Food and Drug Administration has approved a treatment for dermatitis made by Perrigo under a collaboration with Chicago-based Cobrek Pharmaceutical.
The drug maker said Tuesday that the FDA approved ketoconazole foam in the 2% strength. The drug is a generic version of Stiefel Labs’ Extina, a topical drug used to treat seborrheic dermatitis in patients ages 12 years and older with healthy immune systems.
Extina has annual sales of about $10 million, according to Perrigo.
Rx Response puts tool into play in communities impacted by Irene
WASHINGTON — Rx Response late Monday announced it has activated its Pharmacy Reporting Status Tool to aid storm managers and people in communities affected by Hurricane Irene.
“The Pharmacy Status Reporting Tool can play an important role in storm recovery,” Rx Response program director Erin Mullen said. “First, it lets the public know where they can find an open pharmacy in areas hard hit by the storm, so that they can get the medicines they need. Additionally, it helps emergency managers to better meet medical needs in storm-affected areas.”
The Pharmacy Status Reporting Tool provides real-time information on the operating status of pharmacies in communities affected by Hurricane Irene and will cover pharmacies located in Connecticut, Delaware, Maryland, Massachusetts, New Jersey, North Carolina, New Hampshire, Rhode Island, Vermont, Virginia and Washington, D.C., as well as select counties in New York and Pennsylvania, based on Federal Disaster Declarations.
RxResponse is a partnership comprised of participants in the pharmaceutical supply chain that was created in the wake of Hurricane Katrina to help emergency managers’ by providing information on the status of the pharmaceutical supply chain so that they can more effectively respond to natural disasters, man-made emergencies or a terrorist attack.